PE20081375A1 - Derivados octahidro-pirrolo[3,4-c]pirrol como antagonistas del receptor ccr5 - Google Patents
Derivados octahidro-pirrolo[3,4-c]pirrol como antagonistas del receptor ccr5Info
- Publication number
- PE20081375A1 PE20081375A1 PE2007001255A PE2007001255A PE20081375A1 PE 20081375 A1 PE20081375 A1 PE 20081375A1 PE 2007001255 A PE2007001255 A PE 2007001255A PE 2007001255 A PE2007001255 A PE 2007001255A PE 20081375 A1 PE20081375 A1 PE 20081375A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- phenyl
- pirrolo
- octahydro
- antagonists
- Prior art date
Links
- 102000004274 CCR5 Receptors Human genes 0.000 title abstract 2
- 108010017088 CCR5 Receptors Proteins 0.000 title abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical class C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- -1 4,6-DIMETHYL-PYRIMIDINE-5-CARBONYL Chemical class 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 102000019034 Chemokines Human genes 0.000 abstract 1
- 108010012236 Chemokines Proteins 0.000 abstract 1
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- FIULGFJIHJJXMT-UHFFFAOYSA-N [C]1[N]C=CC=C1 Chemical group [C]1[N]C=CC=C1 FIULGFJIHJJXMT-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007813 immunodeficiency Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS OCTAHIDRO-PIRROLO[3,4-c]PIRROL DE FORMULA (I), EN DONDE R1 ES FENILO, PIRIDINILO, PIRIMIDILO, OPCIONALMENTE SUSTITUIDOS CON ALQUILO(C1-C6), HALOALQUILO(C1-C6), ENTRE OTROS; UNO DE R2 Y R3 ES H. Y EL OTRO ES A1, A2 O A3; O BIEN JUNTOS CON (CH2)mNR4(CH2)n; DONDE m Y n SON 1 0 2; R4 ES ALQUILO(C1-C6), HALOALQUILO(C1-C6), CH2C=N, -C(=O)R5 O -SO2R5; Ar ES FENILO OPCIONALMENTE SUSTITUIDO CON HALO, ALQUILO(C1-C6), ENTRE OTROS; R7 ES H O ALQUILO (C1-C3). SON SELECCIONADOS: 4-{2-[5-(4,6-DIMETIL-PIRIMIDINA-5-CARBONIL)-HEXAHIDRO-PIRROLO[3,4-c]PIRROL-2-IL]-ETIL}-4-FENIL-PIPERIDINA-1-CARBOXILATO DE TERT-BUTILO, (5-{2-[1-BENZOIL-4-(3-FLUOR-FENIL)-PIPERIDIN-4-IL]-ETIL}-HEXAHIDRO-PIRROLO[3,4-c]PIRROL-2-IL)-(4,6-DIMETIL-PIRIMIDIN-5-IL)-METANONA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON ANTAGONISTAS DE LOS RECEPTORES CCR5 DE QUIMIOQUINA, SIENDO UTILES EN EL TRATAMIENTO Y PREVENCION DE LA INFECCION DEL VIRUS DE INMUNODEFICIENCIA (VIH)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84533406P | 2006-09-18 | 2006-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081375A1 true PE20081375A1 (es) | 2008-10-17 |
Family
ID=38787632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001255A PE20081375A1 (es) | 2006-09-18 | 2007-09-17 | Derivados octahidro-pirrolo[3,4-c]pirrol como antagonistas del receptor ccr5 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7625905B2 (es) |
| EP (1) | EP2066674B1 (es) |
| JP (1) | JP2010503714A (es) |
| CN (1) | CN101516884A (es) |
| AR (1) | AR062798A1 (es) |
| AT (1) | ATE472549T1 (es) |
| CA (1) | CA2662835A1 (es) |
| CL (1) | CL2007002671A1 (es) |
| DE (1) | DE602007007497D1 (es) |
| ES (1) | ES2345130T3 (es) |
| PE (1) | PE20081375A1 (es) |
| TW (1) | TW200821311A (es) |
| WO (1) | WO2008034731A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2735411T3 (es) | 2009-10-23 | 2019-12-18 | Janssen Pharmaceutica Nv | Octahidropirrolo[3,4-c]pirroles disustituidos como moduladores del receptor de orexina |
| EP2491034B1 (en) | 2009-10-23 | 2013-12-18 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds as orexin receptor modulators |
| JP5848251B2 (ja) | 2009-10-23 | 2016-01-27 | ヤンセン ファーマシューティカ エヌ．ベー． | オレキシン受容体調節因子としての縮合複素環式化合物 |
| US9586962B2 (en) | 2011-04-20 | 2017-03-07 | Janssen Pharmaceutica Nv | Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators |
| WO2012177660A2 (en) | 2011-06-19 | 2012-12-27 | New York University | Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| RS59477B1 (sr) | 2014-03-26 | 2019-12-31 | Hoffmann La Roche | Biciklička jedinjenja kao inhibitori proizvodnje autotaksina (atx) i lizofosfatidne kiseline (lpa) |
| EA201790185A1 (ru) | 2014-07-15 | 2017-07-31 | Грюненталь Гмбх | Замещенные азаспиро(4.5)декановые производные |
| TW201607923A (zh) | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環（４．５）癸烷衍生物 |
| MX387736B (es) | 2015-09-04 | 2025-03-18 | Hoffmann La Roche | Derivados de fenoximetilo. |
| CA2960253A1 (en) | 2016-03-10 | 2017-09-10 | Janssen Pharmaceutica Nv | Methods of treating depression using orexin-2 receptor antagonists |
| CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
| US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0207952A (pt) * | 2001-03-07 | 2004-07-27 | Pfizer Prod Inc | Moduladores da atividade de receptores de quimiocina |
| JP2006511554A (ja) * | 2002-12-13 | 2006-04-06 | スミスクライン ビーチャム コーポレーション | Ｃｃｒ５アンタゴニストとしてのピペリジン誘導体 |
| ES2309400T3 (es) * | 2002-12-13 | 2008-12-16 | Smithkline Beecham Corporation | Compuestos de pirrolidina y azetidina como antagonistas de ccr5. |
| CA2573951A1 (en) * | 2003-07-18 | 2005-01-27 | Virochem Pharma Inc. | Spiro compounds and methods for the modulation of chemokine receptor activity |
| JP2007500694A (ja) | 2003-07-31 | 2007-01-18 | アストラゼネカ・アクチエボラーグ | Ｃｃｒ５受容体モジュレーターとしてのピペリジン誘導体 |
| TW200610761A (en) * | 2004-04-23 | 2006-04-01 | Astrazeneca Ab | Chemical compounds |
| PL1761542T3 (pl) * | 2004-06-09 | 2008-06-30 | Hoffmann La Roche | Pochodne oktahydropirolo[3,4-c]pirolu i ich zastosowanie jako środków przeciwwirusowych |
| SE0401657D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | Chemical compounds |
| SE0403106D0 (sv) | 2004-12-20 | 2004-12-20 | Astrazeneca Ab | Chemical compounds |
| WO2007093520A1 (en) | 2006-02-15 | 2007-08-23 | F. Hoffmann-La Roche Ag | Hetero-bycyclic antiviral compounds |
| CA2641382A1 (en) | 2006-02-15 | 2007-08-23 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
-
2007
- 2007-09-10 WO PCT/EP2007/059453 patent/WO2008034731A1/en active Application Filing
- 2007-09-10 ES ES07803370T patent/ES2345130T3/es active Active
- 2007-09-10 EP EP07803370A patent/EP2066674B1/en not_active Not-in-force
- 2007-09-10 CN CNA2007800345664A patent/CN101516884A/zh active Pending
- 2007-09-10 AT AT07803370T patent/ATE472549T1/de active
- 2007-09-10 JP JP2009528674A patent/JP2010503714A/ja active Pending
- 2007-09-10 CA CA002662835A patent/CA2662835A1/en not_active Abandoned
- 2007-09-10 DE DE602007007497T patent/DE602007007497D1/de active Active
- 2007-09-14 TW TW096134628A patent/TW200821311A/zh unknown
- 2007-09-14 CL CL200702671A patent/CL2007002671A1/es unknown
- 2007-09-17 PE PE2007001255A patent/PE20081375A1/es not_active Application Discontinuation
- 2007-09-17 AR ARP070104100A patent/AR062798A1/es unknown
- 2007-09-18 US US11/901,498 patent/US7625905B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CL2007002671A1 (es) | 2008-04-18 |
| ATE472549T1 (de) | 2010-07-15 |
| US20080103125A1 (en) | 2008-05-01 |
| WO2008034731A1 (en) | 2008-03-27 |
| JP2010503714A (ja) | 2010-02-04 |
| AR062798A1 (es) | 2008-12-03 |
| EP2066674A1 (en) | 2009-06-10 |
| DE602007007497D1 (de) | 2010-08-12 |
| ES2345130T3 (es) | 2010-09-15 |
| CA2662835A1 (en) | 2008-03-27 |
| CN101516884A (zh) | 2009-08-26 |
| TW200821311A (en) | 2008-05-16 |
| US7625905B2 (en) | 2009-12-01 |
| EP2066674B1 (en) | 2010-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20081375A1 (es) | Derivados octahidro-pirrolo[3,4-c]pirrol como antagonistas del receptor ccr5 | |
| PE20090183A1 (es) | Derivados de 1-oxa-3,9-diaza-espiro-[5.5]undecan-2-ona como moduladores de ccr5 | |
| PE20091724A1 (es) | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 | |
| PE20130158A1 (es) | Inhibidores no nucleosidicos de la transcriptasa inversa | |
| PE20120659A1 (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana | |
| PE20120620A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
| PE20110835A1 (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
| PE20120031A1 (es) | Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1 | |
| PE20131377A1 (es) | Triazina-oxadiazoles | |
| PE20120693A1 (es) | Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2) | |
| PE20130281A1 (es) | Derivados de acido 5-alquinil-3-amida-2-tiofeno-carboxilico como inhibidores del virus flaviviridae | |
| PE20141004A1 (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
| PE20051141A1 (es) | Inhibidores de la polimerasa viral | |
| PE20080405A1 (es) | COMPUESTOS Y COMPOSICIONES COMO INHIBIDORES DE ITPKb | |
| PE20090775A1 (es) | Nuevos derivados de biarilo | |
| PE20090546A1 (es) | Derivados de imidazol como antagonistas de los receptores de quimioquina ccr-2, ccr-3 y ccr-5 | |
| PE20081532A1 (es) | Compuestos novedosos | |
| PE20080401A1 (es) | DERIVADOS DE HETEROARIL-FENIL SUSTITUIDOS COMO INHIBIDORES DE B-Raf-QUINASAS | |
| PE20140703A1 (es) | Derivados de heteroarilo como moduladores de nachr alfa 7 | |
| PE20080998A1 (es) | Derivados de pirazol como inhibidores del sistema enzimatico cyp450 | |
| PE20070586A1 (es) | Compuestos de (4-piperidinil)-1,3-dihidro-2h-bencimidazol-2-ona sustituidos como agonistas del receptor muscarinico m1 | |
| PE20090226A1 (es) | PIRROLIDINAMIDAS SUSTITUIDAS COMO INHIBIDORES DEL FACTOR Xa Y SU PREPARACION | |
| PE20060691A1 (es) | Serinamidas sustituidas por benzoilo | |
| PE20080150A1 (es) | Derivados de piridinona n-aril y n-heteroaril sustituidos como antagonistas del receptor de la hormona concentradora de melanina (mch) | |
| PE20091353A1 (es) | Nuevos compuestos heterociclicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |